Quantifying activities of daily living impairment in Parkinson's disease using the Functional Activities Questionnaire

Sara Becker, Claire Pauly, Michael Lawton, Geraldine Hipp, Francesca Bowring, Patricia Sulzer, Michele Hu, Rejko Krüger, Thomas Gasser, Inga Liepelt-Scarfone, Sara Becker, Claire Pauly, Michael Lawton, Geraldine Hipp, Francesca Bowring, Patricia Sulzer, Michele Hu, Rejko Krüger, Thomas Gasser, Inga Liepelt-Scarfone

Abstract

Objective: Cognitive-driven activity of daily living (ADL) impairment in Parkinson's disease (PD) is increasingly discussed as prodromal marker for dementia. Diagnostic properties of assessments for this specific ADL impairment are sparsely investigated in PD. The ability of the Functional Activities Questionnaire (FAQ) for differentiating between PD patients with normal cognition and with mild cognitive impairment (PD-MCI), according to informant and self-reports, was examined. Global cognitive function in groups with and without mild ADL impairment was compared according to different cut-offs.

Methods: Multicenter data of 589 patients of an international cohort (CENTRE-PD) were analyzed. Analyses were run separately for informant-rated and self-rated FAQ. Receiver operating characteristic (ROC) analysis was conducted to define the optimal FAQ cut-off for PD-MCI (≥ 1), and groups were additionally split according to reported FAQ cut-offs for PD-MCI in the literature (≥ 3, ≥ 5). Binary logistic regressions examined the effect of the Montreal Cognitive Assessment (MoCA) score in PD patients with and without mild ADL impairment.

Results: Two hundred and twenty-five (38.2%) patients were classified as PD-MCI. For all three cut-off values, sensitivity was moderate to low (< 0.55), but specificity was moderately high (> 0.54) with a tendency of higher values for self-reported deficits. For the self-report, the cut-off ≥ 3 showed a significant effect of the MoCA (B = - 0.31, p = 0.003), where FAQ ≥ 3 patients had worse cognition. No effect for group differences based on informant ratings was detected.

Conclusion: Our data argue that self-reported ADL impairments assessed by the FAQ show a relation to the severity of cognitive impairment in PD.

Keywords: Cognitive dysfunction; Cohort studies; Mild cognitive impairment; Neuropsychological tests.

Conflict of interest statement

The authors declare no competing interests.

© 2021. The Author(s).

References

    1. Goldman JG, Litvan I. Mild cognitive impairment in Parkinson's disease. Minerva Med. 2011;102(6):441–459.
    1. Lawson RA, et al. Stability of mild cognitive impairment in newly diagnosed Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2017;88(8):648–652. doi: 10.1136/jnnp-2016-315099.
    1. Marshall GA, et al. Functional Activities Questionnaire items that best discriminate and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res. 2015;12(5):493–502. doi: 10.2174/156720501205150526115003.
    1. Altieri M, Garramone F, Santangelo G. Functional autonomy in dementia of the Alzheimer’s type, mild cognitive impairment, and healthy aging: a meta-analysis. Neurol Sci. 2021;42(5):1773–1783. doi: 10.1007/s10072-021-05142-0.
    1. Gold DA. An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment. J Clin Exp Neuropsychol. 2012;34(1):11–34. doi: 10.1080/13803395.2011.614598.
    1. Foster ER. Instrumental activities of daily living performance among people with Parkinson’s disease without dementia. Am J Occup Ther. 2014;68(3):353–362. doi: 10.5014/ajot.2014.010330.
    1. Pirogovsky E, et al. Instrumental activities of daily living are impaired in Parkinson’s disease patients with mild cognitive impairment. Neuropsychology. 2014;28(2):229–237. doi: 10.1037/neu0000045.
    1. Becker S, et al. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson’s patients. J Neuropsychol. 2020;14(1):69–84. doi: 10.1111/jnp.12173.
    1. Glonnegger H, et al. The multiple object test as a performance based tool to assess cognitive driven activity of daily living function in Parkinson’s disease. J Alzheimers Dis. 2016;53(4):1475–1484. doi: 10.3233/JAD-160173.
    1. Pfeffer RI, et al. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323–329. doi: 10.1093/geronj/37.3.323.
    1. Kaur N, et al. Critical appraisal of questionnaires to assess functional impairment in individuals with mild cognitive impairment. Int Psychogeriatr. 2016;28(9):1425–1439. doi: 10.1017/S104161021600017X.
    1. Martyr A, et al. The relationship between perceived functional difficulties and the ability to live well with mild-to-moderate dementia: findings from the IDEAL programme. Int J Geriatr Psychiatry. 2019;34(8):1251–1261. doi: 10.1002/gps.5128.
    1. Becker S et al (2021) Everyday function in Alzheimer’s and Parkinson’s patients with mild cognitive impairment. J Alzheimers Dis 79(1):197–209
    1. Christ JB, et al. How precise are activities of daily living scales for the diagnosis of Parkinson’s disease dementia? A pilot study Parkinsonism Relat Disord. 2013;19(3):371–374. doi: 10.1016/j.parkreldis.2012.11.004.
    1. Shulman LM, et al. Subjective report versus objective measurement of activities of daily living in Parkinson’s disease. Mov Disord. 2006;21(6):794–799. doi: 10.1002/mds.20803.
    1. Liepelt-Scarfone I et al Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia. PLoS One, 2013. 8(12): p. e82902.
    1. Copeland JN, et al. Accuracy of patient and care partner identification of cognitive impairments in Parkinson’s disease-mild cognitive impairment. Mov Disord. 2016;31(5):693–698. doi: 10.1002/mds.26619.
    1. Hipp G, et al. The Luxembourg Parkinson’s Study: a comprehensive approach for stratification and early diagnosis. Front Aging Neurosci. 2018;10:326. doi: 10.3389/fnagi.2018.00326.
    1. Szewczyk-Krolikowski K, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20(1):99–105. doi: 10.1016/j.parkreldis.2013.09.025.
    1. Goetz CG, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170. doi: 10.1002/mds.22340.
    1. Beck AT, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004.
    1. Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi: 10.1111/j.1532-5415.2005.53221.x.
    1. Litvan I, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27(3):349–356. doi: 10.1002/mds.24893.
    1. Bezdicek O, et al. Toward the processing speed theory of activities of daily living in healthy aging: normative data of the Functional Activities Questionnaire. Aging Clin Exp Res. 2016;28(2):239–247. doi: 10.1007/s40520-015-0413-5.
    1. Lawson RA, et al. Severity of mild cognitive impairment in early Parkinson’s disease contributes to poorer quality of life. Parkinsonism Relat Disord. 2014;20(10):1071–1075. doi: 10.1016/j.parkreldis.2014.07.004.
    1. Simundic AM. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009;19(4):203–211.
    1. Choi SM, et al. Analysis of characteristics affecting instrumental activities of daily living in Parkinson’s disease patients without dementia. Neurol Sci. 2019;40(7):1403–1408. doi: 10.1007/s10072-019-03860-0.
    1. Skinner JW, et al. Execution of activities of daily living in persons with Parkinson disease. Med Sci Sports Exerc. 2015;47(9):1906–1912. doi: 10.1249/MSS.0000000000000598.
    1. Lee WJ, et al. Comparison of activities of daily living impairments in Parkinson’s disease patients as defined by the Pill Questionnaire and assessments by neurologists. J Neurol Neurosurg Psychiatry. 2014;85(9):969–973. doi: 10.1136/jnnp-2013-306381.
    1. Ueno T, et al. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson’s disease: a retrospective observational cohort study. Neurol Sci. 2020;41(10):2867–2873. doi: 10.1007/s10072-020-04406-5.
    1. Leroi I, et al. Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol. 2012;25(4):208–214. doi: 10.1177/0891988712464823.
    1. Rosenthal E, et al. Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord. 2010;25(9):1170–1176. doi: 10.1002/mds.23073.
    1. Bloomfield J, Woods D, Ludington J. Self-awareness of memory impairment in Parkinson’s disease: a review of the literature. Working with Older People. 2016;20:57–64. doi: 10.1108/WWOP-08-2015-0019.
    1. Martinez-Martin P, et al. Burden, perceived health status, and mood among caregivers of Parkinson’s disease patients. Mov Disord. 2008;23(12):1673–1680. doi: 10.1002/mds.22106.
    1. Tew EH et al Quality of life in Parkinson’s disease caregivers: the contribution of personality traits. Biomed Res Int, 2013. 2013: p. 151872.
    1. Bjornestad A, et al. Loss of independence in early Parkinson disease: a 5-year population-based incident cohort study. Neurology. 2016;87(15):1599–1606. doi: 10.1212/WNL.0000000000003213.
    1. Tappen RM, Rosselli M, Engstrom G. Evaluation of the Functional Activities Questionnaire (FAQ) in cognitive screening across four American ethnic groups. Clin Neuropsychol. 2010;24(4):646–661. doi: 10.1080/13854040903482855.
    1. Ng A, et al. Influence of depression in mild Parkinson’s disease on longitudinal motor and cognitive function. Parkinsonism Relat Disord. 2015;21(9):1056–1060. doi: 10.1016/j.parkreldis.2015.06.014.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する